Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,615 | -1,555 | -775 | -4,648 | -3,628 |
| Depreciation Amortization | 188 | 120 | 60 | 272 | 184 |
| Accounts receivable | -610 | 499 | 139 | -1,633 | -490 |
| Other Working Capital | -352 | 560 | 572 | -1,077 | -713 |
| Other Operating Activity | 2,099 | 706 | 485 | 4,721 | 2,284 |
| Operating Cash Flow | $-1,290 | $330 | $481 | $-2,365 | $-2,363 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,260 | -1,221 | -863 | -478 | -332 |
| Investing Cash Flow | $-1,260 | $-1,221 | $-863 | $-478 | $-332 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 65 | N/A |
| Debt Repayment | -12 | -8 | -5 | N/A | -55 |
| Common Stock Issued | 2,858 | 2,090 | 1,088 | 3,046 | 2,405 |
| Other Financing Activity | 0 | 0 | 0 | 1,548 | 1,548 |
| Financing Cash Flow | $2,846 | $2,082 | $1,083 | $4,659 | $3,898 |
| Exchange Rate Effect | 47 | 35 | 96 | -128 | -12 |
| Beginning Cash Position | 3,539 | 3,539 | 3,539 | 1,851 | 1,851 |
| End Cash Position | 3,882 | 4,765 | 4,336 | 3,539 | 3,042 |
| Net Cash Flow | $343 | $1,226 | $797 | $1,688 | $1,191 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,290 | 330 | 481 | -2,365 | -2,363 |
| Capital Expenditure | -1,260 | -1,221 | -863 | -478 | -332 |
| Free Cash Flow | -2,550 | -891 | -382 | -2,843 | -2,695 |